How LifeArc’s Neurodegeneration Translational Challenge is leading the charge against Motor Neurone Disease

June 21st is Global MND Awareness Day, a day to raise worldwide awareness of MND (Motor Neurone Disease) and to stand in solidarity with the MND/ALS community.

LifeArc joins the Campaign for Science and Engineering

Network of over 115 members works to put research at the heart of the UK’s future.

LifeArc responds to the Government’s Spring Budget

LifeArc CEO Dr Melanie Lee responds to today's Spring Budget.

Celebrating the International Day of Women and Girls in Science

LifeArc celebrates this year's UN Day for Women and Girls in STEM.

Separate science from politics: save the UK’s science sector

LifeArc's Chief Scientific Officer calls for UK science to continue to be a contributor to the Horizon Europe programme.

Promising new antibody treatment for osteoporosis and multiple sclerosis

The new antibody offers hope of an effective new treatment option for millions of people.

Covid-19 hub shortlisted for Scottish award

Unique translational research hub for Covid-19 and other viruses was a finalist in the Scottish Knowledge Exchange Awards. 

LifeArc bolsters scientific leadership by appointing new Chief Scientific Officer

Welcome to Dr Dave Powell, who has joined LifeArc as our first Chief Scientific Officer (CSO).  Dave is an experienced scientist and leader, with…

New approach provides potential vaccine and treatment for Alzheimer’s

An antibody-based treatment and protein-based vaccine reduced Alzheimer’s symptoms in mouse models of the disease.